文献
J-GLOBAL ID:201702232504328113
整理番号:17A1063227
Eluxadolineは下痢を伴う過敏性腸症候群患者の第2相および第3相研究における乱用可能性の欠如を示す【Powered by NICT】
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea
著者 (5件):
Fant Reginald V.
(Pinney Associates, Bethesda, Maryland)
,
Henningfield Jack E.
(Pinney Associates, Bethesda, Maryland)
,
Cash Brooks D.
(Digestive Health Center, University of South Alabama, Mobile, Alabama)
,
Dove Leonard S.
(Former employee of Furiex Pharmaceuticals, Inc, an affiliate of Allergan plc, Parsippany, New Jersey)
,
Covington Paul S.
(Former employee of Furiex Pharmaceuticals, Inc, an affiliate of Allergan plc, Parsippany, New Jersey)
資料名:
Clinical Gastroenterology and Hepatology
(Clinical Gastroenterology and Hepatology)
巻:
15
号:
7
ページ:
1021-1029.e6
発行年:
2017年
JST資料番号:
W3126A
ISSN:
1542-3565
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)